Ardsley Advisory Partners LP Incyte Corp Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $4.74 Million - $6.45 Million	-75,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $5.48 Million - $7.18 Million	75,000 New	75,000 $6.55 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $7.25 Million - $9.04 Million	-77,500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $8.19 Million - $10.4 Million	75,000 Added 3000.0%	77,500 $9.05 Million
Q2 2017 Sep 21, 2017	BUY	N/A	2,500	2,500 $315,000

641

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.